BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1337 related articles for article (PubMed ID: 31278132)

  • 1. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 4. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
    Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
    Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p.
    Lu H; Gao L; Lv J
    Ann Hepatol; 2022; 27(1):100551. PubMed ID: 34606982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression.
    Yu X; Sheng P; Sun J; Zhao X; Zhang J; Li Y; Zhang Y; Zhang W; Wang J; Liu K; Zhu D; Jiang H
    Cell Death Dis; 2020 May; 11(5):340. PubMed ID: 32393764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
    Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
    J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.
    Yang G; Wang X; Liu B; Lu Z; Xu Z; Xiu P; Liu Z; Li J
    Cell Cycle; 2019 May; 18(9):976-989. PubMed ID: 30931701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Mol Oncol; 2020 Feb; 14(2):447-461. PubMed ID: 31758671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Cao Y; Tao Q; Kao X; Zhu X
    Dig Dis Sci; 2021 May; 66(5):1524-1532. PubMed ID: 32683589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
    Gao J; Yin X; Yu X; Dai C; Zhou F
    J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.